Found 470 articles for: "atopic dermatitis"
An Over-the-Counter Healing Ointment: Benefits in Dry Skin and Wound Healing
May 2024 | Volume 23 | Issue 5 | Original Article | 360 | Copyright © May 2024
Background: The use of ointments can be beneficial for dry, chapped, or cracked skin and also for supporting wound healing. We describe the results of 2 studies with an over-the-...
Read MoreRuxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
May 2024 | Volume 23 | Issue 5 | Case Reports | 378 | Copyright © May 2024
Alopecia areata (AA) is a common autoimmune disorder. Although its pathogenesis is not fully understood, AA involves CD8 T cell-mediated destruction of the hair follicle. Several treatment option...
Read MoreOverview of Radiation Dermatitis: The Dermatologist's Role
May 2024 | Volume 23 | Issue 5 | Features | 381 | Copyright © May 2024
So Let's Design a Peptide . . . A Physician's Approach
May 2024 | Volume 23 | Issue 5 | Features | 347 | Copyright © May 2024
This paper outlines a process undertaken by a physician to design a peptide aimed at impacting the extracellular matrix. From a position of very little expertise, a new peptide was designed with ...
Read MoreDermatologic Education in Under-Resourced Communities: A Collaboration With a Non-Profit and a Student-Run Free Health Clinic
May 2024 | Volume 23 | Issue 5 | Editorials | e128 | Copyright © May 2024
Expression of IL-4 in Tumors: A Safety Surrogate to Predict Cancer Survival Associated With Biologic Therapies
April 2024 | Volume 23 | Issue 4 | Editorials | e118 | Copyright © April 2024
Dermatologists' Perspectives on Biosimilars
April 2024 | Volume 23 | Issue 4 | Features | 277 | Copyright © April 2024
Background: Biosimilars are biologic agents the Food and Drug Administration (FDA) has deemed to have no clinical difference from their reference biologics. In dermatology, biosi...
Read MoreCOVID-19 Protection Strategies: Lessons Learned About Epidermal Barrier Function and the Significance of Optimized Skin Care
April 2024 | Volume 23 | Issue 4 | Original Article | 244 | Copyright © April 2024
Initially categorized as primarily a respiratory disease, COVID-19 can involve other organ systems and may have direct skin manifestations, including exanthems, morbilliform eruption, generalized...
Read MoreAnalysis of Utilization, Cost, and Prescription Trends of Common Immunosuppressive Medications Among Medicare Patients 2013 to 2019
April 2024 | Volume 23 | Issue 4 | Editorials | e113 | Copyright © April 2024
Analysis of Reddit Reveals JAK Inhibitor Questions Among Atopic Dermatitis Patients
April 2024 | Volume 23 | Issue 4 | Editorials | e121 | Copyright © April 2024
Reddit is a popular social media website that is increasingly being used as a source of health information and discussion, especially among the younger population. We analyzed the subreddit "ecze...
Read MoreFULL SUPPLEMENT: Prebiotic Skincare Management of Atopic Dermatitis & Xerosis in Diverse Ethnically Patients
March 2024 | Volume 23 | Issue 3 | Department | SF395747s1 | Copyright © March 2024
Atopic Dermatitis (AD) is a chronic relapsing inflammatory skin disease associated with a significant patient burden on quality-of-life. Rising evidence demonstrate skin microbiome playing an essentia...
Read MoreINDIVIDUAL ARTICLE: Recent Advances in Skincare Management of Atopic Dermatitis in Diverse Racial and Ethnic Groups
March 2024 | Volume 23 | Issue 3 | Supplement Individual Articles | SF395747s4 | Copyright © March 2024
INDIVIDUAL ARTICLE: Atopic Dermatitis Skincare and Impact on Quality of Life for Patients with Skin of Color
March 2024 | Volume 23 | Issue 3 | Supplement Individual Articles | SF395747s6 | Copyright © March 2024
Atopic Dermatitis (AD) epidemiologic studies report a higher incidence and prevalence among populations with skin of color (SOC). Additionally, differences in AD underlying gene mutations and ski...
Read MoreINDIVIDUAL ARTICLE: Efficacy of a Prebiotic Skincare Regimen on Improving Mild Atopic Dermatitis and Severe Xerosis in Diverse Ethnically Patients
March 2024 | Volume 23 | Issue 3 | Supplement Individual Articles | SF395747s12 | Copyright © March 2024
Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease associated with a significant patient burden on quality of life. Given skin barrier including skin microbiome changes are l...
Read MoreNatural Moisturizing Factor-Enriched Formulations Compared to a Ceramide-Based Cream
March 2024 | Volume 23 | Issue 3 | Original Article | 141 | Copyright © March 2024
Background: We aimed to investigate the effects of 2 ceramide plus natural moisturizing factor-enriched formulations compared to aceramide-based cream on skin moistu...
Read MoreA Novel Systems-Wide Approach in Addressing Acne with a Multi-Targeting Nutraceutical
March 2024 | Volume 23 | Issue 3 | Original Article | 160 | Copyright © March 2024
Acne vulgaris (AV) is one of the top concerns dermatologists encounter from women. Until now, therapies addressing AV have largely centered around, and have been successful at, targeting the path...
Read MoreAttenuation of Atopic Dermatitis in Newborns, Infants, and Children With Prescription Treatment and Ceramide-Containing Skin Care: A Systematic Literature Review and Consensus
March 2024 | Volume 23 | Issue 3 | Original Article | 152 | Copyright © March 2024
Background: Atopic dermatitis (AD) typically starts in infancy and early childhood. The chronic skin disorder is associated with recurrent flares, pruritus, and genetic predispos...
Read MoreNovel Clinical Applications of Topical Ruxolitinib: A Case Series
March 2024 | Volume 23 | Issue 3 | Case Reports | 188 | Copyright © March 2024
Topical ruxolitinib, a potent Janus kinase (JAK) inhibitor, has shown significant efficacy in treating inflammatory skin conditions. While its use has already been established in atopic dermatiti...
Read MoreBenefit of Topical Combination Therapy for Acne: Analyzing Effect Size Using Number Needed to Treat
February 2024 | Volume 23 | Issue 2 | Original Article | 42 | Copyright © February 2024
Background: Topical acne trials often are confounded by high vehicle response rates and differing outcome measures, making it difficult to compare treatments. Number needed to tr...
Read MoreNew Insights Into Systemic Drivers of Inflammation and Their Contributions to the Pathophysiology of Acne
February 2024 | Volume 23 | Issue 2 | Original Article | 90 | Copyright © February 2024
Media and other results for: "atopic dermatitis"